Trimurthi Drugs gets board nod for diversification of business
New Delhi: Pharma firm Trimurthi Drugs & Pharmaceuticals' board has approved diversification of its business activities. The board has considered diversification of business activities of the company such as foods and food products, information technology and software consultancy, real estate, construction and warehousing, among others, Trimurthi Drugs & Pharmaceuticals said in a...
Login or Register to read the full article
New Delhi: Pharma firm Trimurthi Drugs & Pharmaceuticals' board has approved diversification of its business activities.
The board has considered diversification of business activities of the company such as foods and food products, information technology and software consultancy, real estate, construction and warehousing, among others, Trimurthi Drugs & Pharmaceuticals said in a BSE filing.
The board has also considered change of the company's name to Trimurthi Ltd or such other name in order to make it in consonance with objects of the company, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd